Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMA FIDELMED from Gent, company number BE0762489086, closed financial year 2025 with a result of € -119,706 after tax. For that financial year PHARMA FIDELMED recorded a gross margin of € 301,937 and equity of € -546,830. Compared with financial year 2024, the result moved from € -38,070 to € -119,706. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ -546,830
▼ € 119,706 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -119,706
▼ 214 % more loss than in 2024
Profit after tax over the fiscal year.
€ 6,151
▼ 72% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -566,830.
People and assets in 2025
2.6
▲ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 175,782
▲ 16% vs 2024
€ 67,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 827,253
▼ 17% vs 2024
Of which on lease € 827,253.
Debts at end 2025
€ 833,824
▼ 16% vs 2024
€ 162,046 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 170,170
▲ 51% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 39,557
▲ 33% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -49,689 | € -77,496 | € 363,474 | € 301,937 | ▼ 17% |
| Profit after taxes | € -153,904 | € -255,150 | € -38,070 | € -119,706 | ▼ € 81,636 |
| Equity | € -133,904 | € -389,055 | € -427,124 | € -546,830 | ▼ € 119,706 |
| Total debts | € 286,903 | € 1,795,588 | € 2,127,614 | € 2,583,135 | ▲ 21% |
| Cash | € 3,013 | € 18,270 | € 22,142 | € 6,151 | ▼ 72% |
| Retained profit | € -153,904 | € -409,055 | € -447,124 | € -566,830 | ▼ € 119,706 |
| Bank debt | € 0 | € 1,132,143 | € 987,119 | € 833,824 | ▼ 16% |
| Balance sheet total | € 152,999 | € 1,406,533 | € 1,700,490 | € 2,036,305 | ▲ 20% |
| Employees (FTE) | 1 | 1.7 | 2.2 | 2.6 | ▲ 0.4 |
Key figures of PHARMA FIDELMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA FIDELMED?
What happened at PHARMA FIDELMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 119,706. Source: NBB ↗
- Mediaxe BV became a director. NBB
- New establishment in Gent. KBO
- SPIDERWEB BV became a director. NBB
- Decura Pharma BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 153,904 loss in 2022 to € 119,706 loss in 2025.
Paid € 581 in corporate taxes since 2022.
On average € 116,100 of value added per employee in 2025.
Management
The stake of FIDELMED comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMA FIDELMEDBehind PHARMA FIDELMED are Mediaxe BV, SPIDERWEB BV and Decura Pharma BV. The shares are held by FIDELMED (100%).
Directors
According to the 2025 annual accounts
since 2025
Director · represented by Toon Coppens
Also active at: REALO, FIDELMED, REDCAT VENTURES
since 2021
Director · represented by Andy Decuypere
Also active at: MEDISALE, Deraphar, LINDEPHAR, APOTHEEK RAES, FIDELMED, HEALTH AND BEAUTY SHOP, DYNA DISTRIBUTION
since 2021
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Waalkens 11 box C
9030 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0762.489.086
- VAT number
- BE 0762.489.086
- Registered office
- Waalkens 11 bus C, 9030 Gent
- Names & denominations
- PHARMA FIDELMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 January 2021
- Peppol
- Active · Active since 6 May 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Overige zakelijke dienstverlening, neg